Amgen will continue to see growth regardless of a recession: CFO

Amgen exceeded revenue expectations in Q2, with sales rising 20%. CFO Griffith anticipates continued growth in the second half of the year, particularly in key segments like cardiovascular and asthma medications, which are essential for patients. The company remains optimistic about its performance despite economic uncertainties.